Featured Articles

1. Time Is Lives: How Collaboration And Urgency Are Rewriting The Future Of Rare Disease 2/19/2026

   The inflection point has arrived, says Rob Freishtat, MD, MPH. Understand how collaboration will rewrite how we think of rare disease clinical research.

2. Activate These Three Levers To Create A More Effective Workforce 2/13/2026

   A convergence of market forces will push life sciences employers to rethink their workforce strategies and reimagine how work gets done, writes Ruby van den Hoff.

3. Why Human Leadership Matters More Than Ever In The AI Era 2/10/2026

   In the AI era, thriving life sciences organizations will differentiate themselves based on their ability to combine AI's power with distinctly human capabilities, writes Christine Ann Miller.

4. Policy Matters: The Reauthorized Rare Pediatric Disease Voucher Program 2/5/2026

   Congress finally reauthorized the Rare Pediatric Disease Priority Review Voucher program, after it expired in 2024. That matters a lot to patients and drug developers, writes George Magrath, M.D. 

5. On The Road: The Business Of Biotech In San Francisco For JPM2026 2/3/2026

   The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and reportage from a selection of interviews, events, and company presentations.

6. Thinking Small: A Counterintuitive Strategy For Biopharma Startups 2/2/2026

   There is more than one way to blockbuster product sales, and sometimes smaller might be better, writes Bennett Smith.

7. A Year Of Separation: Which Advanced Modalities Are Built For Commercial Scale In 2026? 1/30/2026

   In 2026, advanced therapies diverge: winners pair proven biology with scalable manufacturing, delivery, and workflow fit, while others advance more slowly under operational and economic limits.

8. Why 'Be Your Authentic Self' Is Actually Bad Advice 1/23/2026

   Raw authenticity can be disruptive in life sciences workplaces, but learning corporate fluency and stylistic pivots can help leaders become strategically authentic, writes Hope Mueller.

9. A Serial Biotech Entrepreneur's Recipe For Success 1/21/2026

   Pushing boundaries, staying grounded, and having fun along the way are the key ingredients for success in biotech, writes Nuvation Bio Founder, President, and CEO David Hung, M.D.

10. From Lab To Launch: Navigating The Transition To Commercial Readiness 1/13/2026

    Many clinical-stage companies start thinking about commercialization too late. FTI Consulting experts team up to provide guidance on getting started early.